SC
TMO icon

Stance Capital’s Thermo Fisher Scientific TMO Stock Holding History

Stance Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
+3,559
New +$1.71M 0.54% 76
2026
Q1 		– Sell
-2,405
Closed -$1.39M – 319
2025
Q4 		$1.39M Sell
2,405
-398
-14% -$225K 0.51% 74
2025
Q3 		$1.36M Sell
2,803
-426
-13% -$198K 0.5% 84
2025
Q2 		$1.31M Buy
+3,229
New +$1.35M 0.49% 112
2025
Q1 		– Sell
-351
Closed -$183K – 247
2024
Q4 		$183K Buy
+351
New +$193K 0.11% 82

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Stance Capital's TMO Position: Q2 2026 in Review

Stance Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 3,559 shares worth $1.78M. The stake represents 0.54% of the portfolio and ranks #76 among its holdings. This is a return to the name: Stance Capital previously reported a position in TMO as recently as Q4 2025.

Stance Capital first reported a position in TMO in Q4 2024 and has held it in 5 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Stance Capital held 3,559 shares of Thermo Fisher Scientific worth $1.78M as of Q2 2026.
  • Thermo Fisher Scientific was a new Stance Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 0.54% of Stance Capital's portfolio in Q2 2026, its #76 holding.
  • Stance Capital first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 5 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.